Taysha Gene Therapies Inc (NAS:TSHA)
$ 5.02 -0.14 (-2.71%) Market Cap: 1.64 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 4.22 GF Score: 33/100

Taysha Gene Therapies Inc (TSHA) Transcripts

  • 1